SCHEMBL5690802

SCHEMBL5690802

CC(=O)Nc1cc(C)cc(Br)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
HSD17B10 Q99714 2/20 0.53
TDP1 Q9NUW8 2/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
RAB9A P51151 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
GAA P10253 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30487756 1.00 MEN1 (0.59) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL22864579 0.87 LMNA (0.58) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL13735692 0.86 HDAC3 (0.44) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL12781878 0.85 MEN1 (0.70) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL849875 0.85 MEN1 (0.77) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL5453986 0.82 KIF11 (0.47) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL24197589 0.80 LMNA (0.50) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL16143017 0.79 L3MBTL1 (0.52) MEN1KMT2AALDH1A1MAPTHDAC3
SCHEMBL3928712 0.78 LMNA (0.48) MEN1KMT2AHSD17B10TDP1LMNA
SCHEMBL1992521 0.78 ALDH1A1 (0.55) MEN1KMT2AHSD17B10TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-10-24 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
CN-112804982-B Near infrared nerve-retaining benzo [ c ] phenoxazine fluorophores 俄勒冈健康与科学大学 2023-07-25 CN disclosed
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-10 US disclosed
CN-112804982-A Benzo [ c ] phenoxazine fluorophores for near-infrared nerve retention 俄勒冈健康与科学大学 2021-05-14 CN disclosed
WO-2020056046-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2020-03-19 WO disclosed
WO-2018106646-A1 AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed
WO-2018106646-A1 AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed
EP-1227086-B1 1-SUBSTITUTED PHENYL-1-(1H-IMIDAZOL-4-YL) ALCOHOLS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2006-03-29 EP disclosed
US-6518257-B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-02-11 US disclosed
EP-1227086-A1 1-SUBSTITUTED PHENYL-1-(1H-IMIDAZOL-4-YL) ALCOHOLS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-07-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 MEN1 1747/4885KMT2A 2752/4885HSD17B10 1828/4885
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores NTRK1, PMP22, PAX3 MEN1 1747/4885KMT2A 2752/4885HSD17B10 1828/4885
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 MEN1 1747/4885KMT2A 2752/4885HSD17B10 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.